EuroBiotech_What specific expertise does Rentschler Biopharma have in the development and production of bispecific antibodies?
Pollano_At Rentschler Biopharma, our strength lies in our proficiency with highly complex molecules. Our track record of 100 therapeutic protein formats, for a total of about 300 molecules, clearly reflects this expertise. We have almost 20 years of experience in the production of multispecific antibodies, including bispecific and trispecific antibodies. These account for close to one quarter of our development and production portfolio. This is no small feat, and we pride ourselves on the know-how and capabilities that we…